Federated Hermes’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.9M Buy
566,828
+43,339
+8% +$2.35M 0.05% 355
2025
Q4
$24.2M Buy
523,489
+505,333
+2,783% +$22.6M 0.04% 409
2025
Q3
$654K Buy
18,156
+17,895
+6,856% +$593K ﹤0.01% 1271
2025
Q2
$8.48K Buy
+261
New +$8.56K ﹤0.01% 1837
2025
Q1
Sell
-326,058
Closed -$26.7M 2169
2024
Q4
$26.7M Sell
326,058
-174,992
-35% -$17.4M 0.06% 351
2024
Q3
$57.3M Buy
501,050
+75,410
+18% +$6.8M 0.13% 212
2024
Q2
$32.1M Sell
425,640
-110
-0% -$7.49K 0.08% 293
2024
Q1
$29.1M Buy
425,750
+31,558
+8% +$2.19M 0.07% 336
2023
Q4
$24.8M Sell
394,192
-1,615
-0.4% -$83.9K 0.06% 341
2023
Q3
$20.2M Sell
395,807
-627
-0.2% -$30.9K 0.05% 365
2023
Q2
$19.8M Buy
396,434
+319,521
+415% +$15.1M 0.05% 390
2023
Q1
$2.88M Buy
76,913
+76,694
+35,020% +$3.25M 0.01% 842
2022
Q4
$10.5K Buy
+219
New +$8.59K ﹤0.01% 1861

Other funds holding PCVX